Covidien Acquires BARRX Medical for $325,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74a92680-14bd-4e88-88ef-9250c4e78ed7&Preview=1 - Date
11/21/2011 - Company Name
BARRX Medical - Mailing Address
540 Oakmead Parkway Sunnyvale, CA 94085 - Company Description
BARRX Medical, Inc. develops treatment solutions for Barrett’s esophagus, a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. - Website
http://www.barrx.com - Transaction Type
M&A - Transaction Amount
$325,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Covidien will acquire all of the outstanding capital stock of BÂRRX, a private company, for approximately $325 million, with future earn out payments possible based on achievement of specific milestones.
